DANIELLE BURGESS: Open Payments
NPI 1578018990 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$683 in 6 payments from 5 companies in 2025. Trend: 2023 $997 · 2024 $495 · 2025 $683
Food & beverage: $683
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $209 |
| Abbott Laboratories | 1 | $146 |
| Amgen Inc. | 1 | $138 |
| Xeris Pharmaceuticals, Inc. | 1 | $107 |
| Corcept Therapeutics | 1 | $83 |
Products named: PROCLAIM, Livdelzi, RECORLEV, Epclusa, Korlym.
Industry payments across TX — which companies pay providers there.
